510(k) K221640

AlloMap Heart Molecular Expression Testing by Caredx, Inc. — Product Code OJQ

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 13, 2023
Date Received
June 6, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Cardiac Allograft Gene Expression Profiling Test System
Device Class
Class II
Regulation Number
862.1163
Review Panel
CH
Submission Type

In vitro diagnostic multivariate index assay (ivdmia) test service, performed in a single laboratory, for assessing the gene expression profile of rna isolated from peripheral blood mononuclear cells (pbmc) and indicated for use to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (acr) at the time of testing in conjunction with standard clinical assessment.